Dr. Mehta on Stem Cell Transplant in Multiple Myeloma

Jayesh Mehta, MD
Published Online: Friday, Nov 10, 2017



Jayesh Mehta, MD, professor of medicine (hematology and oncology), Feinberg School of Medicine, discusses stem cell transplant in multiple myeloma.

Many people do not like stem cell transplantation, but studies show that eliminating it from treatment only hurts the patient, says Mehta.

With curable diseases with different pathways, it is acceptable to choose 1 form of treatment over another, but that is not the case for incurable diseases, explains Mehta.


Jayesh Mehta, MD, professor of medicine (hematology and oncology), Feinberg School of Medicine, discusses stem cell transplant in multiple myeloma.

Many people do not like stem cell transplantation, but studies show that eliminating it from treatment only hurts the patient, says Mehta.

With curable diseases with different pathways, it is acceptable to choose 1 form of treatment over another, but that is not the case for incurable diseases, explains Mehta.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Optimizing Treatment and Management of Soft Tissue Sarcoma in Community OncologyNov 30, 20171.5
Community Practice Connections™: 1st Annual European Congress on Immunotherapies in Cancer™Dec 13, 20171.5
Publication Bottom Border
Border Publication
x